UCL to pioneer next-generation radiotherapy research

UCL, UCLH and other London partners will receive a £14 million investment from Cancer Research UK (CRUK) to develop techniques to improve radiotherapy. Radiotherapy is a key component of cancer medicine, used as part of treatment for four in 10 cancer patients. The CRUK investment creates "RadNet", a network of seven centres of excellence across the UK. Together the centres will work to improve cancer survival by optimising and personalising radiotherapy. As part of a £56 million CRUK investment announced today, the CRUK City of London Centre, led by Professor Tariq Enver (UCL Cancer Institute), has been awarded £14 million. The partnership includes UCL and UCLH, Queen Mary University of London, King's College London and the Francis Crick Institute. The centre will focus on: the mechanisms of radiation resistance, including cancer evolution and cancer stem cells.